CoChat

Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer

Backus, H.H.J., van Riel, J.M.G.H., van Groeningen, C.J., Vos, W., Dukers, D.F., Bloemena, E., Wouters, D., Pinedo, H.M., Peters, G.J. · 2001 · Annals of Oncology
Cited by 47

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1023/a:1011112227044

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 54

  1. Advanced colorectal cancer meta-analysis project, 1992, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate, J Clin Oncol, 10, 896, 10.1200/JCO.1992.10.6.896 · DOI · Paper page
  2. Peters, 1994, Thymidylate synthase inhibition after administration of 5-fiuorouracil with or without leucovorin; implications for treatment with 5-fluorouracil, J Clin Oncol, 12, 2035, 10.1200/JCO.1994.12.10.2035 · DOI · Paper page
  3. Mini, 1990, Enhancement of the anti-tumor effects of 5-fluorouracil by folinic acid, Pharmacol Ther, 47, 1, 10.1016/0163-7258(90)90042-Z · DOI
  4. Leichman, 1997, Quantification of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin, J Clin Oncol, 15, 3223, 10.1200/JCO.1997.15.10.3223 · DOI · Paper page
  5. Lenz, 1998, P53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival, Clin Cancer Res, 4, 1243
  6. Davies, 1999, Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine, Clin Cancer Res, 5, 325
  7. Aschele, 1999, Immunohistochemical quantification of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy, J Clin Oncol, 17, 1760, 10.1200/JCO.1999.17.6.1760 · DOI · Paper page
  8. Casinu, 1996, Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil, Clin Cancer Res, 5, 1996
  9. Kastan, 1995, P53, cell cycle control and apoptosis Implications for cancer, Cancer Metast Rev, 14, 3, 10.1007/BF00690207 · DOI · Paper page
  10. El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
  11. Weinberg, 1995, The retinoblastoma protein and cell cycle control, Cell, 81, 323, 10.1016/0092-8674(95)90385-2 · DOI · Paper page
  12. Degregori, 1995, Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and GI/S-regulatory genes, Mol Cell Biol, 15, 4215, 10.1128/MCB.15.8.4215 · DOI · Paper page
  13. Miyashita, 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, 9, 1799
  14. Korsmeyer, 1995, Regulators of cell death, Trends Genet, 11, 101, 10.1016/S0168-9525(00)89010-1 · DOI · Paper page
  15. Allen, 1998, Mechanisms controlling cellular suicide: Role of bcl-2 and caspases, Cell Mol Life Sci, 54, 427, 10.1007/s000180050171 · DOI · Paper page
  16. Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 · DOI · Paper page
  17. Lazebnik, 1994, Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE, Nature, 371, 346, 10.1038/371346a0 · DOI · Paper page
  18. Caulin, 1997, Caspase cleavage of Keratin 18 and reorganisation of intermediate filaments during epithelial cell apoptosis, J cell Biol, 138, 1379, 10.1083/jcb.138.6.1379 · DOI · Paper page
  19. Nagata, 1995, The Fas death factor, Science, 267, 1449, 10.1126/science.7533326 · DOI · Paper page
  20. Van Riel JMGH, van Groeningen CJ, Albers SHM et al. Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: Single centre experience in 145 patients Ann Oncol (in press).
  21. Van Triest, 2000, Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody, J Histochem Cytochem, 48, 755, 10.1177/002215540004800604 · doi:10.1177/002215540004800604
  22. Anderson, 1996, Retinoblastoma protein in human breast carcinoma. Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues, J Pathol, 180, 65, 10.1002/(SICI)1096-9896(199609)180:1<65::AID-PATH607>3.0.CO;2-C · DOI
  23. Leers, 1999, Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis, J Pathol, 187, 567, 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J · DOI · Paper page
  24. Lamarra, 1988, Structural and functional analysis of poly(ADP ribose) polymerase: An immunological study, Biochim Biophys Acta, 950, 147, 10.1016/0167-4781(88)90007-3 · DOI
  25. Cifone, 1994, Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase, J Exp Med, 180, 1547, 10.1084/jem.180.4.1547 · DOI · Paper page
  26. Sinicrope, 1998, Loss of p21WAF1/Cipl protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers, Clin Cancer Res, 4, 1251
  27. Fernandes-Alnemri, 1994, CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme, J Biol Chem, 269, 30761, 10.1016/S0021-9258(18)47344-9 · DOI · Paper page
  28. Mann, 1999, FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas, Br J Cancer, 79, 1262, 10.1038/sj.bjc.6690202 · DOI
  29. Van Triest, 2000, Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet derived endothelial cell growth factor, and proliferation markers in colorectal cancer, Clin Cancer Res, 6, 1063
  30. Kanavaros, 1999, Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas, Med Oncol, 16, 23, 10.1007/BF02787355 · DOI
  31. Mosnier, 1996, An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum, Arch Pathol Lab Med, 120, 654
  32. Krajewska, 1996, Elevated expression of bcl-x and reduced bak in primary colorectal adenocarcinomas, Cancer Res, 56, 2422
  33. Krajewska, 1994, Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2, Am J Pathol, 145, 1323
  34. Krajewska, 1995, Immunohistochemical analysis of mcl-l protein in human tissues, Am J Pathol, 146, 1309
  35. Backus HHJ, Dukers DF, van Groeningen CJ et al. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients. Ann Oncol (in press).
  36. Bobrow, 1989, Catalyzed reporter deposition, a novel method of signal amplification. I Application for immunoassays, J Immunol Methods, 125, 279, 10.1016/0022-1759(89)90104-X · DOI · Paper page
  37. Poller, 1997, P53 and Rbl protein expression Are they prognostically useful in colorectal cancer?, Br J Cancer, 75, 87, 10.1038/bjc.1997.14 · DOI
  38. Sinicrope, 1995, Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis, Cancer Res, 55, 237
  39. Sinicrope, 1999, Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas, Clin Cancer Res, 5, 1793
  40. Lenz, 1998, P53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival, and site. Clin Cancer Res, 4, 1227
  41. Yoong, 1999, Fas/Fas ligand interaction in human colorectal hepatic metastases, Am J Pathol, 154, 693, 10.1016/S0002-9440(10)65316-3 · DOI
  42. Ogura, 1999, Prognostic significance of bcl-2, bcl-xL/S, bax and bak expressions in colorectal carcinomas, Oncol Rep, 6, 365
  43. Fleege, 1990, Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry, Lab Invest, 63, 270
  44. Dukers, 2000, Quantitative immuno-histochemical analysis of cytokine profiles in Epstein–Barr virus-positive and -negative cases of Hodgkin’s disease, J Pathol, 190, 143, 10.1002/(SICI)1096-9896(200002)190:2<143::AID-PATH519>3.0.CO;2-5 · doi:10.1002/(sici)1096-9896(200002)190:2<143::aid-path519>3.0.co;2-5
  45. Paradiso, 2000, Thymidylate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients, Br J Cancer, 82, 560, 10.1054/bjoc.1999.0964 · DOI
  46. Ali, 1993, Rbl protein in normal and malignant human colorectal tissue and colon cancer cell lines, FASEB J, 7, 931, 10.1096/fasebj.7.10.8344490 · DOI
  47. Van Triest, 2000, Downstream molecular determinants of response to 5-fluorouracil and antifolate synthase inhibitors, Ann Oncol, 11, 385, 10.1023/A:1008351221345 · DOI · Paper page
  48. Dix, 1994, Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas, Br J Cancer, 70, 585, 10.1038/bjc.1994.355 · DOI
  49. Belluco, 1996, P53 nuclear protein overexpression in colorectal cancer: A dominant predictor of survival in patients with advanced hepatic metastases, J Clin Oncol, 14, 2696, 10.1200/JCO.1996.14.10.2696 · DOI
  50. Paradiso, 1996, P53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis, Int J Cancer, 69, 437, 10.1002/(SICI)1097-0215(19961220)69:6<437::AID-IJC2>3.0.CO;2-5 · doi:10.1002/(sici)1097-0215(19961220)69:6<437::aid-ijc2>3.0.co;2-5
  51. Brett, 1996, P53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer, Eur J Sur Oncol, 22, 182, 10.1016/S0748-7983(96)90827-6 · DOI
  52. Nita, 1998, 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of bcl-2 family proteins, Br J Cancer, 78, 986, 10.1038/bjc.1998.617 · DOI · Paper page
  53. Peters, 2000, Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed, Eur J Cancer, 36, 916, 10.1016/S0959-8049(00)00026-5 · DOI
  54. Schneider, 1997, Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas, Br J Cancer, 75, 427, 10.1038/bjc.1997.70 · DOI

Cited by

See all 47

Metadata

Authors
Backus, H. H. J., van Riel, J. M. G. H., van Groeningen, C. J., Vos, W., Dukers, D. F., Bloemena, E., Wouters, D., Pinedo, H. M., & Peters, G. J.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2001-06
Volume
12
Issue
6
Pages
779-785
ISSN
0923-7534
Cited by
47
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.